Intrinsic Value of S&P & Nasdaq Contact Us

Cardio Diagnostics Holdings, Inc. CDIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cardio Diagnostics Holdings, Inc. (CDIO) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $-10.80 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-9.30 vs est $-10.80 (beat +13.9%). 2025: actual $-3.71 vs est $-6.90 (beat +46.2%). Analyst accuracy: 49%.

CDIO Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Cardio Diagnostics Holdings, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — CDIO

49%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$9.30 vs Est –$10.80 ▲ 16.1% off
2025 Actual –$3.71 vs Est –$6.90 ▲ 86.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — CDIO

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 57.6% off
2025 Actual $0.000B vs Est $0.001B ▼ 3,441.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message